Brief: GSK Says Filing Accepted By EMA For Trelegy Ellipta Use In Adult Patients With Asthma

Innoviva

27/02/2020 15:01

Feb 27 (Reuters) - GlaxoSmithKline PLC  GSK.L :
    * GSK FILING ACCEPTED BY EUROPEAN MEDICINES AGENCY FOR
TRELEGY
ELLIPTA USE IN ADULT PATIENTS WITH ASTHMA
    * SUBMISSION SUPPORTED BY PIVOTAL CAPTAIN STUDY SHOWING
SIGNIFICANT IMPROVEMENT IN LUNG FUNCTION COMPARED WITH ICS/LABA,
RELVAR/BREO ELLIPTA 
    * REGULATORY APPLICATIONS ALSO SUBMITTED FOR TRELEGY
DUPLICATE
LICENCES, ELEBRATO ELLIPTA, TEMYBRIC ELLIPTA

Further company coverage:  GSK.L   INVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))